Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us
Family with two young children

Indications for pharmacogenomic testing in Australia

Home Our project areas Genomic implementation projects 2022 Indications for pharmacogenomic testing in…

Summary

Medication doesn’t always have the same effect for each individual: two patients can experience highly variable responses to the same drug, which can have serious implications for patients, as well costing billions to the Australian health system. Many factors influencing the safety and efficacy of medication are influenced by a person’s genes, but a lack of understanding and confidence in pharmacogenomic testing often prevents its use in practice. This has caused a large gap between current practice and what is best practice in drug and dose selection in Australia.  

The Royal College of Pathologists (RCPA) leads this initiative, partnering with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Pharmaceutical Society of Australia (PSA) to generate publicly available indications and guidelines for pharmacogenomic testing in Australia. The project will also establish a generic template for pharmacogenomic MSAC applications, as well as two of its own submissions for the MBS funding of tests for the most urgent pharmacogenomic tests.

Project Lead

Royal College of Pathologists of Australia


More projects

Building genomic knowledge in partnership with Indigenous communities and health services

Improving diagnostic pathways for rare diseases in regional Australia

Genomics in schools: Resources to engage students in the translation of genomics to the real world

Connect with us

(03) 9936 6345
info@australiangenomics.org.au
50 Flemington Road, Parkville
Victoria 3052 Australia

In the spirit of reconciliation Australian Genomics acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

To stay informed about our work, sign up to our newsletter

Subscribe

Quicklinks

  • Home
  • What we do
  • What we offer
  • Tools & resources
  • Our publications
  • Our project areas
  • Research we’re supporting
  • Our team

Privacy

  • We follow the Australian Privacy Principles
  • General privacy policy
  • Website privacy policies
  • Terms & conditions

Website by Blueboat.